Bioventus BVS
NASDAQ BVS
$13.64 -0.19 (-1.41%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bioventus (BVS) Assets Growth (3y) (2023 - 2026)

Analysis

Bioventus (BVS) Assets Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Bioventus 923.70 Mn 894.24 Mn 105.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 -6.99%
Mar 28, 2026 -9.83%
Dec 31, 2025 -20.74%
Sep 27, 2025 -20.53%
Jun 28, 2025 -16.38%
Mar 29, 2025 -16.72%
Dec 31, 2024 -15.95%
Sep 28, 2024 5.53%
Jun 29, 2024 7.00%
Mar 30, 2024 7.29%
Dec 31, 2023 17.93%